Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Mepivacaine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel dimethyl carbonate methylation process for mepivacaine. Enhances safety, reduces cost, ensures high purity for pharmaceutical supply chains.
Patent CN103073484A details a green synthesis of mepivacaine using dimethyl carbonate, offering safer alternatives to toxic methylating agents for API manufacturing.
Patent CN103073483A reveals a safe, high-yield route for Mepivacaine using formic acid. Discover cost-effective manufacturing and reliable supply chain solutions.